Actavis agrees deal with FDA on manufacturing problems
January 9, 2009Manufacturing and Production Actavis
Generic drug manufacturer Actavis will continue the lockdown of its New Jersey manufacturing facilities that breached quality standards, but hopes …
UK biotech forced to hang on for government aid
January 9, 2009Research and Development biotech
Cash-stricken UK biotech has been left hanging on for government funding, without any guarantee it will get the support needed. …
UK pharma to lose
January 8, 2009Sales and Marketing ABPI, NHS, par
The UK pharmaceutical industry stands to lose £225 million in annual profits under its new pricing agreement with the government. …
Lifeline for troubled LyondellBasell
January 8, 2009Manufacturing and Production Lyondell, excipients
LyondellBasell, the world’s third-largest petrochemical company and a supplier of a number of pharmaceutical raw materials, has filed for Chapter …
Novartis boosts vaccine pipeline
January 8, 2009Research and Development, Sales and Marketing Novartis, recruitment, vaccines
Novartis has added an investigational vaccine to its pipeline through a $20 million deal with AlphaVax. The North Carolina-based biotech …
Working Life: Les Hughes
January 8, 2009Research and Development AstraZeneca, Cancer, clinical research, infection
How did you find your way into your role? I wanted to be a chemist from my very first experience …
Government ups the ante on GP surveys
January 7, 2009NHS, primary
Patients are to be surveyed more often in a government bid to further improve GP services. The survey has been …
PMCPA cautions on the way new prices are promoted
January 7, 2009Sales and Marketing par, reg
UK pharma companies have been warned not to mislead doctors about new lower prices of medicines. Code of Practice regulator …
The Pharmafocus Interview: Elmar Schnee
January 6, 2009Sales and Marketing EU, Germany, IQWIG, Merck Serono, cost-effectiveness
Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …
NICE makes end-of-life drugs more available
January 6, 2009Sales and Marketing NICE, par
High-cost drugs that extend the lives of terminally ill patients will be more readily approved for NHS use, thanks to …
Most acute NHS trusts independent from government
January 5, 2009NHS
More than half of all acute NHS trusts have now been awarded foundation status, making them free to operate outside …
GSK halts political funding
January 5, 2009Sales and Marketing GSK, ethics
GlaxoSmithKline will no longer make corporate political donations in a bid to make its dealings with governments more transparent and …
Abraxis Biosciences launches Abraxane in Europe
January 2, 2009Sales and Marketing Abraxis, Cancer, EU
US biotech company Abraxis BioScience has launched its innovative breast cancer treatment Abraxane in Europe. The drug is a variant …
BMS denies further 10% staff cut
January 2, 2009Sales and Marketing BMS, restructure
Bristol Myers Squibb has denied claims it is making a further 10% reduction to its work force, and said any …
NHS 2008: Rejuvenating the 60 year-old service
December 31, 2008Sales and Marketing NHS, collaborations, healthcare, industry relations, pharma
A review of the NHS in 2008 NHS-pharma collaborations come of ageIn January, new guidelines were agreed to help NHS …
Biotech in 2008
December 31, 2008Research and Development Genentech, InClone, biotech, economy, investment
The credit crunch hits biotechBy October Europe's biotech sector was feeling severe effects from the credit crunch, with small and …
2008: A year in the life of UK pharma
December 31, 2008Research and Development, Sales and Marketing 2008, YIR, patients, pharma, review, social networking, year in review
Patient power proves decisive in battle for accessSocial networking helped a new breed of informed patient advocates win the …
Amgen could be Pfizer takeover target
December 18, 2008Sales and Marketing Amgen, MA, Pfizer
Pfizer could be preparing itself to buy Amgen to maintain its lead in the sector, according to a leading analyst. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
